Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 3/20 | 1.00 |
| ▸ | SYNJ2 | O15056 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.85 |
| ▸ | MAPT | P10636 | 3/20 | 0.85 |
| ▸ | HES1 | Q14469 | 2/20 | 0.85 |
| ▸ | FANCF | Q9NPI8 | 2/20 | 0.85 |
| ▸ | POLB | P06746 | 2/20 | 0.85 |
| ▸ | GAA | P10253 | 2/20 | 0.85 |
| ▸ | XDH | P47989 | 2/20 | 0.85 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.85 |
| ▸ | KDM1A | O60341 | 1/20 | 0.85 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.85 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.85 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.85 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.85 |
| ▸ | CFTR | P13569 | 1/20 | 0.85 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.85 |
| ▸ | MAOA | P21397 | 1/20 | 0.85 |
| ▸ | ACHE | P22303 | 1/20 | 0.85 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Narcissin SCHEMBL31236364 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL1305421 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL30389758 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL1305418 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL7167500 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL15773535 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL31236367 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Rutin SCHEMBL6427268 | 0.95 | P4HB (0.90) | P4HBSYNJ2KDM4EMAPTHES1 | |
| SCHEMBL30305712 | 0.95 | P4HB (0.90) | P4HBSYNJ2KDM4EMAPTHES1 | |
| SCHEMBL25292788 | 0.94 | P4HB (0.89) | P4HBSYNJ2KDM4EMAPTHES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094564-A | Method for controlling phytopathogenic fungi | — | 2026-05-26 | — | — | CN | disclosed |
| EP-3468369-B1 | USE OF A CELLULAR EXTRACT FROM ONE OR MORE MICROALGAE OF THE GENUS AMPHIDINIUM FOR ITS FUNGICIDAL ACTIVITY ON FUNGI AND/OR OOMYCETES | IMMUNRISE BIOCONTROL FRANCE (FR) | 2026-02-25 | — | — | EP | disclosed |
| US-20250311734-A1 | Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections | NOVOZYMES A/S (DK) | 2025-10-09 | — | — | US | disclosed |
| EP-4525615-A2 | COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, SUPRESSING AND/OR ELIMINATING PHYTOPATHOGENIC INFESTATIONS AND INFECTIONS | Novozymes A/S (DK) | 2025-03-26 | — | — | EP | disclosed |
| CN-112180698-B | Toner and method for producing the same | 佳能株式会社 | 2024-12-17 | — | — | CN | disclosed |
| US-20240294864-A1 | CHLORELLA-BASED PRODUCTION OF EXTRACELLULAR VESICLE-EMBEDDED SMALL RNAS FOR BIOCONTROL APPLICATIONS | IRT (FR) | 2024-09-05 | — | — | US | disclosed |
| US-20240276987-A1 | Compositions and Methods for Improving the Rainfastness of Proteins on Plant Surfaces | NOVOZYMES A/S (DK) | 2024-08-22 | — | — | US | disclosed |
| EP-4369930-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE RAINFASTNESS OF PROTEINS ON PLANT SURFACES | Novozymes A/S (DK) | 2024-05-22 | — | — | EP | disclosed |
| EP-4360456-A1 | PHYTOSANITARY FORMULATION | Universidad de Almeria (ES) | 2024-05-01 | — | — | EP | disclosed |
| CN-117700354-A | Crystal form of raffinancin and preparation method thereof | 江苏百奥信康医药科技有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-115768403-A | Mouthwash for oral care benefits | 费尔廷制药公司 | 2023-03-07 | — | — | CN | disclosed |
| WO-2023288294-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE RAINFASTNESS OF PROTEINS ON PLANT SURFACES | NOVOZYMES A/S (DK) | 2023-01-19 | — | — | WO | disclosed |
| WO-2023284777-A1 | COPOLYMER FILM, ENZYME CATALYSIS SELF-ASSEMBLY SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF | 中国科学院天津工业生物技术研究所 | 2023-01-19 | — | — | WO | disclosed |
| WO-2022269118-A1 | PHYTOSANITARY FORMULATION | UNIVERSIDAD DE ALMERÍA (ES) | 2022-12-29 | — | — | WO | disclosed |
| CN-109843068-B | Use of a cell extract of one or more microalgae of the genus prototheca for fungicidal and/or bactericidal activity against fungi, oomycetes and/or pathogenic bacteria of plants and cultured seeds | 免疫生物防治法国公司 | 2022-11-15 | — | — | CN | disclosed |
| CN-110849988-B | Method for detecting 33 alkaloids in honey | 徐敦明 | 2022-08-16 | — | — | CN | disclosed |
| CN-114134232-B | Application of HDS in predicting prognosis of gastric cancer patient, guiding postoperative adjuvant chemotherapy and predicting curative effect of immunotherapy | 北京大学人民医院 | 2022-04-15 | — | — | CN | disclosed |
| US-11286456-B2 | Large scale production of liquid and solid trichoderma products | LOCUS AGRICULTURE IP COMPANY, LLC (US) | 2022-03-29 | — | — | US | disclosed |
| EP-3967745-A1 | CHLORELLA-BASED PRODUCTION OF EXTRACELLULAR VESICLE-EMBEDDED SMALL RNAS FOR BIOCONTROL APPLICATIONS | Immunrise (FR) | 2022-03-16 | — | — | EP | disclosed |
| CN-114134232-A | Application of HDS in predicting prognosis of gastric cancer patient, guiding postoperative adjuvant chemotherapy and predicting curative effect of immunotherapy | 北京大学人民医院 | 2022-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250311734-A1 | Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections | RNGTT, PPA1, NOP2 | P4HB 1593/4885SYNJ2 1585/4885KDM4E 4615/4885 |
| US-20240276987-A1 | Compositions and Methods for Improving the Rainfastness of Proteins on Plant Surfaces | TASP1, ACP1, DDOST | P4HB 791/4885SYNJ2 2402/4885KDM4E 3957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.